2D Chemical StructureDatabase ID 15951529
No renderable structure data available
SMILES
CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)CStructure data verified · Database ID 15951529
Chemical Intermediate
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
CAS 915087-33-1Product ID 672277
| Intermediates | 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide |
|---|---|
| IUPAC Name | — |
| CAS Number | 915087-33-1 |
| Database ID | 15951529 |
| Molecular Formula | — |
| Molecular Weight | — |
Product Information
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide (CAS 915087-33-1) product identity, structure identifiers and related reaction data for chemical intermediate research and sourcing review.
CAS Number915087-33-1
Database ID15951529
Molecular Formula—
Updated2025-04-09
Potential Applications
Potential Applications
For professional research and industrial use only
Database ID 15951529
Computed Properties
Exact Mass—
XLogP—
Topological Polar Surface Area—
Hydrogen Bond Donors—
Hydrogen Bond Acceptors—
Rotatable Bonds—
- IUPAC Name
- —
- InChIKey
- —
- SMILES
- CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
- InChI
- —
Safety Notice
Safety & Notes
For professional research and industrial use only. Review the supplier safety data sheet before handling.
PubChem References
Public References
These sources are listed in the compound's public database record.
Request a Quote
Need this intermediate?
Send the required specification, quantity, destination and intended use. The CATO team will review availability and respond.
CAS 915087-33-14-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
Complete inquiry